A meta-analysis of data from 2102 patients obtained in 11 placebo-controlled clinical trials [23] showed that for men taking tadalafil Supplement 146 Vol. 2, No. 1, pp. 141–157, March 2005 20 mg, the mean per-patient rate of successful intercourse (SEP3) was 68% compared to 31% for placebo (p < 0.001). At the end of the 12- weeks, 71% (tadalafil 10 mg) and 84% (tadalafil 20 mg) of men responded via the GAQ that tadalafil had improved their erections compared to 33% taking placebo (p < 0.001).
No comments:
Post a Comment